ID   HM2 [Mouse hybridoma against human GPC1]
AC   CVCL_E8DD
DR   ABCD; ABCD_BF007
RX   Patent=US12122843;
RX   PubMed=32623934;
WW   Provider; NCI TTC; TAB-4107/E-028-2019-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4107
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35052; Human GPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=32623934; DOI=10.1369/0022155420933709; PMCID=PMC7711243;
RA   Li, Nan
RA   Spetz, Madeline R.
RA   Ho, Mitchell
RT   "The role of glypicans in cancer progression and therapy.";
RL   J. Histochem. Cytochem. 68:841-862(2020).
//
RX   Patent=US12122843;
RA   Ho, Mitchell
RA   Li, Nan
RA   Pan, Jia-Jia
RT   "High affinity monoclonal antibodies targeting glypican-1 and methods
RT   of use.";
RL   Patent number US12122843, 22-Oct-2024.
//